We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Ft Fdn | LSE:FDN | London | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
6.50 | 0.24% | 2,750.75 | 2,741.00 | 2,760.50 | 35 | 16:35:10 |
RNS Number:2431D Fieldens PLC 01 November 2002 FIELDENS PLC ('FIELDENS' OR 'THE COMPANY') Directors' Interest Derek Bonham and Andrew Arends, respectively Chairman and Chief Executive of the Company, have today agreed, conditional on the completion of the proposed acquisition by the Company of CamAxys Limited ('Proposed Acquisition') announced on 29 October 2002, each to purchase 222,335 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 28 pence per Ordinary Share from Barbara Fielden, who resigned from the Board of Fieldens on 25 October 2002. Following this purchase, Derek Bonham and Andrew Arends would each have an interest in 969,835 Ordinary Shares representing 14.88 per cent. of the issued share capital of the Company as enlarged by any Ordinary Shares issued on completion of the Proposed Acquisition ('Enlarged Share Capital') and 19.40 per cent. of the current issued share capital of the Company. In aggregate, Derek Bonham and Andrew Arends will therefore be interested in 1,939,670 Ordinary Shares representing 29.76 per cent. of the Enlarged Share Capital and 38.79 per cent of the current issued share capital of the Company. Also following this purchase, Barbara Fielden would be interested in 805,330 Ordinary Shares representing 12.35 per cent. of the Enlarged Share Capital and 16.11 per cent. of the current issued share capital of the Company. Under the terms of the Proposed Acquisition, up to 2,510,667 new Ordinary Shares are payable to the shareholders of CamAxys. 1,519,207 of these shares are to be issued on completion of the Proposed Acquisition ('Initial Consideration Shares') and 991,460 are subject to adjustment on account of CamAxys' borrowings at completion and completion accounts ('Deferred Initial Consideration Shares'). Further performance related consideration of up to 2,478,654 new Ordinary Shares ('Further Consideration Shares') may become payable after 30 June 2005. Derek Bonham and Andrew Arends have also committed, following the issue by the Company of any Deferred Initial Consideration Shares following completion of the Proposed Acquisition, each to purchase from Barbara Fielden an amount of Ordinary Shares equal to 29.99 per cent. of the amount of any Deferred Initial Consideration Shares issued by the Company. Completion of the Proposed Acquisition is expected to occur on 21 November 2002 when dealings in the Enlarged Share Capital are expected to commence trading on the Alternative Investment Market of the London Stock Exchange. Colin West, who is expected to join the Board of Fieldens following completion of the Proposed Acquisition, would, assuming completion in full of the Proposed Acquisition, including that the full number of performance related Further Consideration Shares are issued and that no adjustment is made to the number of Deferred Initial Consideration Shares issued by the Company, be interested in 649,901 Ordinary Shares, representing 6.51 per cent. of the maximum issued share capital of the Company as a result of the Proposed Acquisition (not 2.53 per cent. as disclosed in the Admission Document dated 29 October 2002). 1 November 2002 For further information Andrew Arends, Chief Executive Fieldens PLC 07767 238 864 Graham Shore/ Jonathan Nelson Shore Capital 020 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange END RDSFSLFFFSESEDF
1 Year Ft Fdn Chart |
1 Month Ft Fdn Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions